← Leaderboards
Amal O Amer
Ohio State University
$14,350,541
Attributed
$24,585,004
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.1M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,635,666 · 17
By mechanism
R01$20,427,244 · 8
P01$7,684,495 · 3
R21$2,523,927 · 6
Top collaborators
- Estelle A Cormet-Boyaka16 shared
- Stephanie M M Seveau10 shared
- Santiago Partida-Sanchez6 shared
- Prosper N Boyaka5 shared
- Purnima Dubey5 shared
- Luanne Hall-Stoodley4 shared
- Benjamin T Kopp4 shared
- Jacob Yount3 shared
Most similar at Ohio State University
Same institution · by research overlap
- Estelle A Cormet-Boyaka$4,545,799
- Nagaraj Kerur$4,973,912
- Jianrong Li$9,360,578
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsImmuneInfectionResponseMediatingMacrophageBacteriaAlzheimer&AposIn VitroInflammationLungProteinsInflammatoryIn VivoProductionLysosomesMolecularPublishingPathogenGenesCaspaseCell DeathAutophagocytosisLead
Grant awards (56)
Role of the Non-canonical Inflammasome in SARS-CoV-2-mediated Pathology and Coagulopathy$3,004,517
P01 · FY2025 · AI · contact PI
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY$726,247
R01 · FY2025 · AI · contact PI
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infections$716,669
R01 · FY2025 · HL
Targeting specific MicroRNA to alleviate Alzheimerâs Disease pathobiology$671,739
R01 · FY2025 · AG · contact PI
Host Responses to the Pore-Forming Toxin Listeriolysin O$636,587
R01 · FY2025 · AI
Resue of CF phagocyte function with CFTR modulator therapy$503,459
R01 · FY2025 · HL
Administrative Core$429,218
P01 · FY2025 · AI · contact PI
Caspr/11-dependent immunothrombosis and neuroinflammation during SARS-CoV-2 infection$429,216
P01 · FY2025 · AI · contact PI
Role of the Non-canonical Inflammasome in SARS-CoV-2-mediated Pathology and Coagulopathy$3,046,145
P01 · FY2024 · AI · contact PI
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY$737,407
R01 · FY2024 · AI · contact PI
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infections$702,336
R01 · FY2024 · HL
Targeting specific MicroRNA to alleviate Alzheimerâs Disease pathobiology$685,448
R01 · FY2024 · AG · contact PI
Caspr/11-dependent immunothrombosis and neuroinflammation during SARS-CoV-2 infection$652,551
P01 · FY2024 · AI · contact PI
Host Responses to the Pore-Forming Toxin Listeriolysin O$644,081
R01 · FY2024 · AI
Resue of CF phagocyte function with CFTR modulator therapy$493,389
R01 · FY2024 · HL
Administrative Core$122,848
P01 · FY2024 · AI · contact PI
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infections$749,419
R01 · FY2023 · HL
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY$748,912
R01 · FY2023 · AI · contact PI
Targeting specific MicroRNA to alleviate Alzheimerâs Disease pathobiology$674,566
R01 · FY2023 · AG · contact PI
Host Responses to the Pore-Forming Toxin Listeriolysin O$644,081
R01 · FY2023 · AI
Resue of CF phagocyte function with CFTR modulator therapy$531,709
R01 · FY2023 · HL
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY$739,358
R01 · FY2022 · AI · contact PI
Host Responses to the Pore-Forming Toxin Listeriolysin O$671,723
R01 · FY2022 · AI
Rescue of CF phagocyte function with CFTR modulator therapy$611,287
R01 · FY2022 · HL
Susceptibility determinants to Legionella pneumophila infection in smokers$195,000
R21 · FY2022 · AI · contact PI
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY$755,265
R01 · FY2021 · AI · contact PI
Host Responses to the Pore-Forming Toxin Listeriolysin O$594,733
R01 · FY2021 · AI
Susceptibility determinants to Legionella pneumophila infection in smokers$234,000
R21 · FY2021 · AI · contact PI
Alzheimerâs Disease Biomarker for Diagnosis and Prognosis$188,808
R21 · FY2021 · AG · contact PI
Mechanistic basis of inflammation in Alzheimers Disease$184,680
R21 · FY2021 · AG · contact PI
Restoring macrophage function in cystic fibrosis$511,273
R01 · FY2020 · AI · contact PI
Unraveling the role of the CFTR ion channel in susceptibility to SARS-CoV-2 infection and inflammation$460,500
R01 · FY2020 · AI · contact PI
Restoring macrophage function in cystic fibrosis$312,000
R01 · FY2020 · AI · contact PI
Alzheimer's Disease Biomarker for Diagnosis and Prognosis$228,159
R21 · FY2020 · AG · contact PI
Mechanistic basis of inflammation in Alzheimers Disease$224,264
R21 · FY2020 · AG · contact PI
Restoring macrophage function in cystic fibrosis$511,273
R01 · FY2019 · AI · contact PI
Restoring macrophage function in cystic fibrosis$390,000
R01 · FY2019 · AI · contact PI
Restoring macrophage function in cystic fibrosis$511,273
R01 · FY2018 · AI · contact PI
The role of microRNA-calibrated autophagy in innate immunity and inflammation$378,555
R01 · FY2018 · HL · contact PI
Restoring macrophage function in cystic fibrosis$509,733
R01 · FY2017 · AI · contact PI
The role of microRNA-calibrated autophagy in innate immunity and inflammation$378,908
R01 · FY2017 · HL · contact PI
Calcium dependent mechanisms of neutrophil dysfunction that contribute to cystic fibrosis pathobiology$226,650
R21 · FY2017 · AI
Restoring macrophage function in cystic fibrosis$509,733
R01 · FY2016 · AI · contact PI
The role of microRNA-calibrated autophagy in innate immunity and inflammation$385,328
R01 · FY2016 · HL · contact PI
Calcium dependent mechanisms of neutrophil dysfunction that contribute to cystic fibrosis pathobiology$200,580
R21 · FY2016 · AI
Human susceptibility to Legionella infection$191,143
R21 · FY2016 · AI · contact PI
The role of microRNA-calibrated autophagy in innate immunity and inflammation$386,967
R01 · FY2015 · HL · contact PI
Human susceptibility to Legionella infection$243,143
R21 · FY2015 · AI · contact PI
Role of caspases in Legionella pneumophila pulmonary infection$362,752
R01 · FY2013 · HL · contact PI
Role of caspases in Legionella pneumophila pulmonary infection$425,240
R01 · FY2012 · HL · contact PI
Role of caspases in Legionella pneumophila pulmonary infection$375,000
R01 · FY2011 · HL · contact PI
Role of caspases in Legionella pneumophila pulmonary infection$30,294
R01 · FY2011 · HL · contact PI
Role of caspases in Legionella pneumophila pulmonary infection$375,000
R01 · FY2010 · HL · contact PI
How can caspases control intracellular pulmonary pathogens$187,500
R21 · FY2010 · AI · contact PI
Role of caspases in Legionella pneumophila pulmonary infection$375,000
R01 · FY2009 · HL · contact PI
How can caspases control intracellular pulmonary pathogens$220,000
R21 · FY2009 · AI · contact PI